These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 12987688

  • 1. Ganglionic blocking agents with special reference to the effect of hexamethonium on the cardiovascular system.
    PATON WD.
    Br Med Bull; 1952; 8(4):310-5. PubMed ID: 12987688
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of a ganglion-blocking agent, hexamethonium bitartrate on the induction of experimental erythema in guinea pigs and man].
    PANCONESI E.
    Rass Dermatol Sifilogr; 1955; 8(3):149-74. PubMed ID: 13290051
    [No Abstract] [Full Text] [Related]

  • 3. The effect of a ganglion-blocking drug, hexamethonium, on the response of the cat's carotid body to various stimuli.
    DOUGLAS WW.
    J Physiol; 1952 Nov; 118(3):373-83. PubMed ID: 13000765
    [No Abstract] [Full Text] [Related]

  • 4. Certain cardiovasculorenal effects of hexamethonium.
    WAKIM KG.
    Am Heart J; 1955 Sep; 50(3):435-41. PubMed ID: 14398635
    [No Abstract] [Full Text] [Related]

  • 5. Studies on cholinergic-blocking substances. VI. The pharmacology of hexamethonium- and pendiomid type ganglionic-blocking compounds.
    GYERMEK L.
    Acta Physiol Acad Sci Hung; 1954 Sep; 5(1-2):163-79. PubMed ID: 13147923
    [No Abstract] [Full Text] [Related]

  • 6. Further cardiovascular and renal hemodynamic studies following the administration of hydralazine (1-hydrazinophthalazine) and the effect of ganglionic blockade with hexamethonium on these responses.
    MOYER JH, HUGGINS RA, HANDLEY CA.
    J Pharmacol Exp Ther; 1953 Oct; 109(2):175-82. PubMed ID: 13097349
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of a synthetic ganglion blocking agent derived from thiophanium (arfonad) on visceral circulation].
    BENELLI C, ROUGIER G.
    C R Seances Soc Biol Fil; 1956 Nov 18; 150(6):1191-2. PubMed ID: 13383932
    [No Abstract] [Full Text] [Related]

  • 8. The physiological action of neuromuscular and ganglionic blocking agents.
    BURN JH.
    Br J Anaesth; 1957 Jun 18; 29(6):242-8. PubMed ID: 13436684
    [No Abstract] [Full Text] [Related]

  • 9. [Utilization of certain ganglion blocking agents and results of their use in neurosurgery; hexamethonium, C-9295].
    PETIT-DUTAILLIS D, GUIOT G, DAMOISEAU B.
    Pathol Gen; 1952 Nov 18; 52(642):651-68. PubMed ID: 13037410
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of ganglion blocking agents on metabolic variations].
    GUGLIELMI F, BELSASSO E.
    G Ital Anestesiol; 1952 Nov 18; 18(5):530-4. PubMed ID: 13021502
    [No Abstract] [Full Text] [Related]

  • 11. Effect of hexamethonium chloride on cardiovascular and renal hemodynamics and on electrolyte excretion.
    MOYER JH, HUGGINS RA, HANDLEY CA, MILLS LC.
    J Pharmacol Exp Ther; 1952 Oct 18; 106(2):157-65. PubMed ID: 12981638
    [No Abstract] [Full Text] [Related]

  • 12. Clinical assessment of drugs which inhibit gastric secretion with special reference to hexamethonium.
    ROWLANDS EN, WOLFF HH, ATKINSON M.
    Lancet; 1952 Dec 13; 2(6746):1154-8. PubMed ID: 12991752
    [No Abstract] [Full Text] [Related]

  • 13. The effect of some newer ganglionic blocking agents on accommodation.
    BLODI FC.
    Am J Ophthalmol; 1956 Nov 13; 42(5):747-51. PubMed ID: 13372697
    [No Abstract] [Full Text] [Related]

  • 14. Neuromuscular and ganglionic blocking action of thiamine and its derivatives.
    DI PALMA JR, HITCHCOCK P.
    Anesthesiology; 1958 Nov 13; 19(6):762-9. PubMed ID: 13595256
    [No Abstract] [Full Text] [Related]

  • 15. Studies on tolerance to ganglionic blocking agents in man; reversal of depressor action of quaternary ammonium compounds.
    DONTAS AS, HOOBLER SW.
    Circulation; 1954 Dec 13; 10(6):887-95. PubMed ID: 13209769
    [No Abstract] [Full Text] [Related]

  • 16. Renal participation in enhanced pressor responses to noradrenaline in patients given hexamethonium.
    CORCORAN AC, WAGNER WE, PAGE IH.
    J Clin Invest; 1956 Aug 13; 35(8):868-73. PubMed ID: 13345888
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative investigations of ganglionic blocking substances, of sympatholytics, of parasympatholytics in experimental pulmonary embolisms].
    BEIN HJ.
    Experientia; 1952 Feb 15; 8(2):67-9. PubMed ID: 14945409
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacological characterization of autonomic drugs in tissue metabolism of the salivary gland. I. Spasmolytics and ganglion-blocking agents].
    BROCK N, DRUCKREY H.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954 Feb 15; 223(4):314-31. PubMed ID: 13223808
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of hexamethonium on kidney function].
    LIPS AC.
    Ned Tijdschr Geneeskd; 1952 Dec 06; 96(49):3057-63. PubMed ID: 13046538
    [No Abstract] [Full Text] [Related]

  • 20. Relaxants and the human cardio-vascular system.
    JOHNSTONE M.
    Anaesthesia; 1955 Apr 06; 10(2):122-38. PubMed ID: 14376826
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.